AZD1222 (ChAdOx1 nCoV-19) Vaccine: Hurdles and Visions

AZD1222 (ChAdOx1 nCoV-19) Vaccine: Hurdles and Visions

ChAdOx1 nCoV-19 (AZD1222) is a replication-deficient chimpanzee adenovirus vectored vaccine developed by Oxford and AstraZeneca for a disease we all know as Coronavirus, or COVID-19. Ongoing clinical studies reveal that the ChAdOx1 nCoV-19 vaccine has a tolerable safety profile and is effective agai...

Full description

Bibliographic Details
Main Authors: Md. Altamash Ahmad, Harleen Kaur, Pratima Kumari, Ravinder Singh, Rupinder Kaur, Hitesh Chopra, Ojus Sardana, Talha Bin Emran, Kuldeep Dhama
Format: Article
Language:English
Published: Journal of Pure and Applied Microbiology 2023-03-01
Series:Journal of Pure and Applied Microbiology
Subjects:
sars-cov-2
chadox1 ncov-19
health
complications
thrombocytopenia
Online Access:https://microbiologyjournal.org/azd1222-chadox1-ncov-19-vaccine-hurdles-and-visions/

Internet

https://microbiologyjournal.org/azd1222-chadox1-ncov-19-vaccine-hurdles-and-visions/

Similar Items